ATE308314T1 - Zusammensetzung für inhalierung enthaltend delta- 9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel - Google Patents

Zusammensetzung für inhalierung enthaltend delta- 9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel

Info

Publication number
ATE308314T1
ATE308314T1 AT00957496T AT00957496T ATE308314T1 AT E308314 T1 ATE308314 T1 AT E308314T1 AT 00957496 T AT00957496 T AT 00957496T AT 00957496 T AT00957496 T AT 00957496T AT E308314 T1 ATE308314 T1 AT E308314T1
Authority
AT
Austria
Prior art keywords
tetrahydrocannabinol
semi
aqueous solvent
delta
composition
Prior art date
Application number
AT00957496T
Other languages
English (en)
Inventor
Andrea M Mcphillips
Julia J Economou
Mahendra G Dedhiya
Beverly Ann Wynne
Original Assignee
Unimed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals Inc filed Critical Unimed Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE308314T1 publication Critical patent/ATE308314T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT00957496T 1999-08-20 2000-08-15 Zusammensetzung für inhalierung enthaltend delta- 9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel ATE308314T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15002399P 1999-08-20 1999-08-20
PCT/US2000/022495 WO2001013886A1 (en) 1999-08-20 2000-08-15 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent

Publications (1)

Publication Number Publication Date
ATE308314T1 true ATE308314T1 (de) 2005-11-15

Family

ID=22532791

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00957496T ATE308314T1 (de) 1999-08-20 2000-08-15 Zusammensetzung für inhalierung enthaltend delta- 9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel

Country Status (14)

Country Link
EP (1) EP1212039B1 (de)
JP (1) JP2003535813A (de)
CN (1) CN1187093C (de)
AT (1) ATE308314T1 (de)
AU (1) AU779324B2 (de)
CA (1) CA2382217A1 (de)
DE (1) DE60023720T2 (de)
DK (1) DK1212039T3 (de)
ES (1) ES2246883T3 (de)
IL (2) IL148241A0 (de)
MX (1) MXPA02001804A (de)
NO (1) NO20020835L (de)
NZ (1) NZ517517A (de)
WO (1) WO2001013886A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7648696B2 (en) 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
US6747058B1 (en) 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
DK1280515T3 (da) 2000-03-09 2007-06-11 Gw Pharma Ltd Farmaceutiske sammensætninger omfattende cannabis
GB2361869B (en) * 2000-03-09 2004-09-22 Pharmasol Ltd Sublingual delivery of cannabis
ATE533472T1 (de) * 2002-08-14 2011-12-15 Gw Pharma Ltd Flüssige cannabinoid-formulierungen zur verabreichung an die schleimhäute
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
CA2623723A1 (en) 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
GB2431105A (en) 2005-10-12 2007-04-18 Gw Pharma Ltd Cannabinoids for the treatment of pulmonary disorders
GB2524469A (en) * 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
EP4151234A1 (de) * 2014-05-29 2023-03-22 Fresh Cut Development, LLC Stabile cannabinoidformulierungen
US12544389B2 (en) 2014-05-29 2026-02-10 Fresh Cut Development, Llc Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
EP3160445B1 (de) 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Mdi-verwandte produkte und verfahren zur verwendung
CN110200953B (zh) * 2019-06-15 2022-02-08 汉义生物科技（北京）有限公司 大麻素在制备吸入给药药物中的应用
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

Also Published As

Publication number Publication date
DE60023720D1 (de) 2005-12-08
WO2001013886A1 (en) 2001-03-01
NO20020835D0 (no) 2002-02-20
DE60023720T2 (de) 2006-07-20
CN1187093C (zh) 2005-02-02
EP1212039A1 (de) 2002-06-12
HK1056318A1 (en) 2004-02-13
NO20020835L (no) 2002-04-02
ES2246883T3 (es) 2006-03-01
IL148241A (en) 2007-02-11
NZ517517A (en) 2004-03-26
AU6910700A (en) 2001-03-19
IL148241A0 (en) 2002-09-12
AU779324B2 (en) 2005-01-20
CN1420761A (zh) 2003-05-28
JP2003535813A (ja) 2003-12-02
MXPA02001804A (es) 2004-09-06
DK1212039T3 (da) 2005-12-19
EP1212039B1 (de) 2005-11-02
CA2382217A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
DE60023720D1 (de) Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
US4912124A (en) Antifungal dermatological solution
KR950007858A (ko) 정맥내 주사용 라파마이신 제형
ES2120247T3 (es) Soluciones estables de budesonida, procedimiento para su preparacion, asi como empleo de estas soluciones como preparados para enemas y espumas farmaceuticas.
ES2110543T3 (es) Derivados de poli(vinil-aminas) que tienen centros hidrofilos, procedimiento para su preparacion asi como la utilizacion de los compuestos como medicamentos, vehiculos de sustancias activas e ingredientes auxiliares para alimentos.
FI934000A0 (fi) Nya estrar av bi- och tricykliska aminoalkoholer, deras framstaellning och deras anvaendning i laekemedel
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
DE602004016856D1 (de) Hfc lösungsformulierungen enthaltend ein anticholinergikum
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
AR085989A2 (es) Composiciones endoparasiticidas y proceso para su preparacion
MY101536A (en) Anti-inflammatory and analgesic tape for external use
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
KR850004389A (ko) 경피침투가 증진된 생리학적 활성제제의 제조방법
MXPA06000243A (es) Formulacion farmaceutica liofilizada estable de tetrodotoxina.
ES2171525T3 (es) Composiciones farmaceuticas para uso topico conteniendo acido (s)-2-(4-isobutilfenil)propionico.
AU4419497A (en) Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
KR950008468A (ko) 방향족 카복실산 유도체
ATE129898T1 (de) Cyclosporin enthaltende orale pharmazeutische zusammensetzung sowie verfahren zu deren herstellung.
DE69804169D1 (de) Oral anzuwendende flüssige Arzneilösung
KR910005869A (ko) 한개 이상의 에틸렌이민기를 가지는 항신생 화합물에 대한 안정한, 주입 가능한 제약학적 조성물 및 그의 제조 방법
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
JPS58152808A (ja) 含嗽剤組成物
EP0156508A1 (de) Fungizide Aerosol-Lösung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1212039

Country of ref document: EP

REN Ceased due to non-payment of the annual fee